These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 17110830)

  • 21. Manic symptoms probably associated with short-term low-dose quetiapine use.
    Erberk-Ozen N
    Adv Ther; 2008 Jan; 25(1):53-8. PubMed ID: 18224291
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quetiapine-induced hypothyroidism.
    Ramaswamy S; Siddiqui Z; Saharan S; Gabel TL; Bhatia SC
    J Psychiatry Neurosci; 2005 Jan; 30(1):57. PubMed ID: 15645000
    [No Abstract]   [Full Text] [Related]  

  • 23. Weight gain in a patient with schizophrenia switched from quetiapine to amisulpride.
    Chen YY; Huang MC; Wu KC
    Psychiatry Clin Neurosci; 2008 Oct; 62(5):620-1. PubMed ID: 18950385
    [No Abstract]   [Full Text] [Related]  

  • 24. An analysis of safety and tolerability data from controlled, comparative studies of quetiapine in patients with schizophrenia, focusing on extrapyramidal symptoms.
    Timdahl K; Carlsson A; Stening G
    Hum Psychopharmacol; 2007 Jul; 22(5):315-25. PubMed ID: 17542047
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Priapism associated with routine use of quetiapine: case report and review of the literature.
    Davol P; Rukstalis D
    Urology; 2005 Oct; 66(4):880. PubMed ID: 16230163
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quetiapine-induced dystonia and agitation in Parkinson's disease with dementia: a case report.
    Leey J; Setters B; Murphy P; Antimisiaris D; Miles T
    J Am Geriatr Soc; 2009 May; 57(5):918-9. PubMed ID: 19470011
    [No Abstract]   [Full Text] [Related]  

  • 27. Possible case of quetiapine-induced rhabdomyolysis in a patient with depression treated with fluoxetine.
    Himmerich H; Ehrlinger M; Hackenberg M; Löhr B; Nickel T
    J Clin Psychopharmacol; 2006 Dec; 26(6):676-7. PubMed ID: 17110835
    [No Abstract]   [Full Text] [Related]  

  • 28. Sexual functioning associated with quetiapine switch vs. risperidone continuation in outpatients with schizophrenia or schizoaffective disorder: a randomized double-blind pilot trial.
    Byerly MJ; Nakonezny PA; Rush AJ
    Psychiatry Res; 2008 May; 159(1-2):115-20. PubMed ID: 18295343
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Urinary retention following repeated high-dose quetiapine.
    Sokolski KN; Brown BJ; Melden M
    Ann Pharmacother; 2004 May; 38(5):899-900. PubMed ID: 15039480
    [No Abstract]   [Full Text] [Related]  

  • 30. Acute polydipsia and water intoxication in first episode schizophrenia.
    Zilles D; Hasan A; Gruber O; Degner D
    Aust N Z J Psychiatry; 2010 May; 44(5):489. PubMed ID: 20397795
    [No Abstract]   [Full Text] [Related]  

  • 31. Evaluation of the feasibility of switching from immediate release quetiapine to extended release quetiapine fumarate in stable outpatients with schizophrenia.
    Möller HJ; Johnson S; Mateva T; Brecher M; Svensson O; Miller F; Meulien D;
    Int Clin Psychopharmacol; 2008 Mar; 23(2):95-105. PubMed ID: 18301124
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy and safety of quetiapine for depressive symptoms in patients with schizophrenia.
    Lee KU; Jeon YW; Lee HK; Jun TY
    Hum Psychopharmacol; 2009 Aug; 24(6):447-52. PubMed ID: 19606454
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Myasthenic crisis may mimic antipsychotic-induced extrapyramidal syndromes.
    Chiu YH; Yang AC; Chern CH; How CK
    J Neuropsychiatry Clin Neurosci; 2011; 23(2):E36-7. PubMed ID: 21677221
    [No Abstract]   [Full Text] [Related]  

  • 34. Open-label steady-state pharmacokinetic drug interaction study on co-administered quetiapine fumarate and divalproex sodium in patients with schizophrenia, schizoaffective disorder, or bipolar disorder.
    Winter HR; DeVane CL; Figueroa C; Ennis DJ; Hamer-Maansson JE; Davis PC; Smith MA
    Hum Psychopharmacol; 2007 Oct; 22(7):469-76. PubMed ID: 17729385
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A 12-month, open-label, comparative study of quetiapine and risperidone in the acute and long-term treatment of schizophrenia.
    Perez V; Cañas F; Tafalla M;
    Int Clin Psychopharmacol; 2008 May; 23(3):138-49. PubMed ID: 18408528
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Drug-induced Pisa syndrome under quetiapine.
    Walder A; Greil W; Baumann P
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Oct; 33(7):1286-7. PubMed ID: 19646500
    [No Abstract]   [Full Text] [Related]  

  • 37. Quetiapine-induced dose-dependent hypersalivation in mania.
    Oulis P; Masdrakis VG; Karakatsanis NA; Kouzoupis AV; Papadimitriou GN
    Clin Neuropharmacol; 2009; 32(1):56-7. PubMed ID: 19471187
    [No Abstract]   [Full Text] [Related]  

  • 38. Quetiapine-related dysphagia.
    Armstrong D; Ahuja N; Lloyd AJ
    Psychosomatics; 2008; 49(5):450-2. PubMed ID: 18794516
    [No Abstract]   [Full Text] [Related]  

  • 39. Delirium associated with lithium-quetiapine combination.
    Miodownik C; Alkatnany A; Frolova K; Lerner V
    Clin Neuropharmacol; 2008; 31(3):176-9. PubMed ID: 18520985
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intravenous quetiapine abuse.
    Hussain MZ; Waheed W; Hussain S
    Am J Psychiatry; 2005 Sep; 162(9):1755-6. PubMed ID: 16135642
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.